Dose titration of BAF312 attenuates the initial heart rate reducing effect in healthy subjects.
about
Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel-group, phase I study in healthy subjects.Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.Bitopic Sphingosine 1-Phosphate Receptor 3 (S1P3) Antagonist Rescue from Complete Heart Block: Pharmacological and Genetic Evidence for Direct S1P3 Regulation of Mouse Cardiac Conduction.The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis.Clinical pharmacology, efficacy, and safety aspects of sphingosine-1-phosphate receptor modulators.Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.Impact of siponimod on vaccination response in a randomized, placebo-controlled study.Cardiac Safety of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator: Results of a Thorough QT/QTc Study.Modeling Tolerance Development for the Effect on Heart Rate of the Selective S1P1 Receptor Modulator Ponesimod.Mitigation of Initial Cardiodynamic Effects of the S1P1 Receptor Modulator Ponesimod Using a Novel Up-Titration Regimen.Fingolimod-induced decrease in heart rate may predict subsequent decreasing degree of lymphocytes
P2860
Q33593619-9B31C08F-0BD2-4DCE-B0FF-8E1C99B047FFQ33753317-89C9C2F4-8444-4673-BBD2-71951E542249Q33880223-83925ECB-8939-4E36-A85F-2F7FF1C1946FQ36432399-B5007CE6-DEF0-4239-8E12-4CC919C8406AQ38303665-7D05EC19-4163-4131-A9E6-676D516DC7B6Q38622668-83908B3E-7AF5-4274-B383-26D655871C0BQ38850104-8B249915-23CE-4717-B2D5-66B527149C9DQ38966334-4388830A-3D72-4412-A190-B97996F63D14Q41686869-9AA497F0-F8E5-4409-985C-F0FDB566CFADQ46025818-F149DE3C-CB85-467F-A433-80364A9BCDB3Q47980601-6102CCFB-6701-43A9-A82D-47A29EB19AA0Q51552299-4F90F922-7209-4AB0-99EC-4EFA8404A2A6Q58608733-00648B4D-3B0D-45A0-9CE3-C70ECE8C0BED
P2860
Dose titration of BAF312 attenuates the initial heart rate reducing effect in healthy subjects.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dose titration of BAF312 atten ...... ng effect in healthy subjects.
@ast
Dose titration of BAF312 atten ...... ng effect in healthy subjects.
@en
type
label
Dose titration of BAF312 atten ...... ng effect in healthy subjects.
@ast
Dose titration of BAF312 atten ...... ng effect in healthy subjects.
@en
prefLabel
Dose titration of BAF312 atten ...... ng effect in healthy subjects.
@ast
Dose titration of BAF312 atten ...... ng effect in healthy subjects.
@en
P2093
P2860
P1476
Dose titration of BAF312 atten ...... ng effect in healthy subjects.
@en
P2093
Anne Gardin
Donald Johns
Eric Legangneux
P2860
P304
P356
10.1111/J.1365-2125.2012.04400.X
P407
P577
2013-03-01T00:00:00Z